Cargando…
Identification of SARS-CoV-2 inhibitors through phylogenetics and drug repurposing
The novel coronavirus that has affected the whole world is declared a pandemic by the World Health Organization. Since the emergence of this virus, researchers worldwide have searched for potential antivirals against it. Being an RNA virus, it shows a high rate of mutability and variability in its g...
Autores principales: | Mishra, Anamika, Mulpuru, Viswajit, Mishra, Nidhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315090/ https://www.ncbi.nlm.nih.gov/pubmed/35910782 http://dx.doi.org/10.1007/s11224-022-02019-6 |
Ejemplares similares
-
Computational Identification of SARS-CoV-2 Inhibitor in Tinospora cordifolia, Cinnamomum zeylanicum and Myristica fragrans
por: Mulpuru, Viswajit, et al.
Publicado: (2021) -
Immunoinformatic based identification of cytotoxic T lymphocyte epitopes from the Indian isolate of SARS-CoV-2
por: Mulpuru, Viswajit, et al.
Publicado: (2021) -
In Silico Prediction of Fraction Unbound in Human
Plasma from Chemical Fingerprint Using Automated Machine Learning
por: Mulpuru, Viswajit, et al.
Publicado: (2021) -
Discovery of Novel Coumarin Analogs against the α-Glucosidase Protein Target of Diabetes Mellitus: Pharmacophore-Based QSAR, Docking, and Molecular Dynamics Simulation Studies
por: Maurya, Akhilesh Kumar, et al.
Publicado: (2020) -
Applying polypharmacology approach for drug repurposing for SARS-CoV2
por: Jamir, Esther, et al.
Publicado: (2022)